State of Wisconsin Investment Board’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-187,610
Closed -$16M 2045
2020
Q3
$16M Buy
187,610
+58,053
+45% +$2.94M 0.04% 451
2020
Q2
$4.59M Sell
129,557
-264,620
-67% -$7.74M 0.01% 914
2020
Q1
$5.31M Buy
394,177
+51,160
+15% +$861K 0.02% 761
2019
Q4
$7.26M Buy
343,017
+81,217
+31% +$1.43M 0.02% 801
2019
Q3
$3.47M Buy
261,800
+43,900
+20% +$645K 0.01% 903
2019
Q2
$3.02M Buy
217,900
+13,700
+7% +$206K 0.01% 951
2019
Q1
$3.92M Buy
204,200
+57,600
+39% +$928K 0.01% 867
2018
Q4
$2.09M Hold
146,600
0.01% 962
2018
Q3
$3.05M Buy
146,600
+12,400
+9% +$294K 0.01% 969
2018
Q2
$3.18M Buy
134,200
+31,400
+31% +$631K 0.01% 934
2018
Q1
$1.5M Buy
102,800
+21,800
+27% +$356K ﹤0.01% 1020
2017
Q4
$1.31M Hold
81,000
﹤0.01% 1042
2017
Q3
$1.13M Hold
81,000
﹤0.01% 1058
2017
Q2
$715K Buy
+81,000
New +$569K ﹤0.01% 1177
2015
Q3
Sell
-1,500,000
Closed -$6.09M 1350
2015
Q2
$6.09M Hold
1,500,000
0.02% 770
2015
Q1
$5.75M Buy
+1,500,000
New +$6.52M 0.02% 774

State of Wisconsin Investment Board's IMMU Position: Q4 2020 in Review

State of Wisconsin Investment Board sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 187,610 shares — an estimated $16M sold.

State of Wisconsin Investment Board first reported a position in IMMU in Q1 2015 and held it in 16 quarters. The position peaked at $16M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • State of Wisconsin Investment Board reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 187,610 Immunomedics Inc shares in Q4 2020, an estimated $16M.
  • State of Wisconsin Investment Board first reported a position in Immunomedics Inc in Q1 2015 and held it in 16 quarters.
  • State of Wisconsin Investment Board's Immunomedics Inc position peaked at $16M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2020, filed 3 Feb 2021.